Consistently, it was reported that IL-6 production levels in the early phase of RSV infection are correlated with the limitation of disease severity through its effect on maturation of regulatory T cells [187], whereas high concentrations of IL-6 in the late phase of infection correlate with respiratory failure, ARDS, and adverse clinical outcomes [188]. The gene discussed is IL6; the disease is infection.